Another oncoprotein of fusion-type tyrosine kinase, the EML4-ALK, results from the inversion within the short arm of the human chromosome 2 in 4–5% of cases of NSCLC (40). The gene discussed is ALK; the disease is non-small cell lung carcinoma.